1,5 Anhydroglucitol and 1,5 Anhydroglucitol / Glycated Hemoglobin Ratio as a Potential Biomarker for Islet β-cell Function and Insulin Resistance Among Patients With Type 2 Diabetes Mellitus

Clinical trial NCT04869605 · UNKNOWN

Trial details

NCT number: NCT04869605
Sponsor: Cairo University
Status: UNKNOWN
Study type: OBSERVATIONAL

Diabetes Mellitus

Start date: 2021-05-06
Primary completion: 2022-07-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.